| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.95▲ | 1.99▼ | 2.01▼ | 1.95▼ | 1.47▲ |
| MA10 | 1.98▼ | 2.03▼ | 2.05▼ | 1.85▲ | 1.15▲ |
| MA20 | 2.02▼ | 2.02▼ | 1.95▲ | 1.43▲ | 1.06▲ |
| MA50 | 2.01▼ | 1.93▲ | 1.92▲ | 1.07▲ | 1.12▲ |
| MA100 | 1.96▼ | 1.86▲ | 1.56▲ | 1.03▲ | 3.65▼ |
| MA200 | 1.92▲ | 1.46▲ | 1.23▲ | 1.09▲ | 3.67▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | -0.017▼ | -0.009▼ | 0.055▲ | 0.163▲ |
| RSI | 35.487▼ | 45.512▼ | 49.949▼ | 64.833▲ | 69.837▲ |
| STOCH | 1.111▼ | 1.157▼ | 45.066 | 82.863▲ | 76.248 |
| WILL %R | -96.000▼ | -97.500▼ | -54.930 | -19.183▲ | -15.787▲ |
| CCI | -85.446 | -154.641▼ | -46.234 | 79.391 | 210.618▲ |
|
Tuesday, August 26, 2025 04:36 AM
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...
|
|
Monday, August 25, 2025 11:29 PM
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune ...
|
|
Thursday, August 21, 2025 07:17 AM
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 2.14 | 2.17 | 1.94 | 1.94 | 365,000 |
| 16/09/25 | 1.81 | 2.15 | 1.76 | 2.14 | 547,019 |
| 15/09/25 | 1.94 | 1.96 | 1.76 | 1.79 | 326,871 |
| 12/09/25 | 1.98 | 2.01 | 1.91 | 1.92 | 252,100 |
| 11/09/25 | 1.68 | 2.00 | 1.68 | 1.98 | 518,954 |
| 10/09/25 | 2.00 | 2.027 | 1.69 | 1.75 | 844,100 |
| 09/09/25 | 1.90 | 2.04 | 1.74 | 2.01 | 1,428,107 |
| 08/09/25 | 1.65 | 1.945 | 1.59 | 1.88 | 3,131,200 |
| 05/09/25 | 1.50 | 1.56 | 1.45 | 1.55 | 1,438,532 |
| 04/09/25 | 1.28 | 1.53 | 1.19 | 1.51 | 1,778,498 |
|
|
||||
|
|
||||
|
|